MOULSFORD MEDICAL LIMITEDActive

Company number 12315604Private limited companyIncorporated 2019

Key figures

£74,570-36.6%
Net assets 2024/25
+40.6%
Average annual growth 2019/20–2024/25
050 k100 k150 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, MOULSFORD MEDICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover240,056————
Profit for the year138,546————
Cash at bank and in hand—100,586———
Total assets112,717101,288148,472181,334235,124
Total liabilities33,728———160,554
Net assets / total equity78,98979,43198,302117,61474,570
Average number of employees22369
Average pay (per year)6,665————

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MOULSFORD MEDICAL LIMITED

Company

MOULSFORD MEDICAL LIMITED is a private limited company registered with Companies House under company number 12315604. It was incorporated on 14 Nov 2019. Its status is active. The registered office is in Wallingford (OX10). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Nov 2025); the company files micro-entity accounts. Net assets were £74,570, down 36.6% on the previous year. Total assets were £235,124 and total liabilities £160,554. The company had an average of 9 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Aug 2027. The next confirmation statement is due by 27 Nov 2026.